With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.7787-70-4,Copper(I) bromide,as a common compound, the synthetic route is as follows.
7787-70-4, A mixture of PLN(37.6 mg, 0.2 mmol) containing CH3ONa (11.8 mg, 0.22 mmol) andCuBr (22 mg, 0.2 mmol) in methanolic solution (10 mL) was refluxed for 2 h, followed by addition of 1,10-phenanthroline (36 mg,0.2 mmol) in methanol (10 mL). The mixture was stirred for another 30 min at room temperature to give a dark-red solution and then filtered.The filtrate was kept in air for a week, forming dark-red block crystals. The crystals were isolated, washed three times with distilled water and dried in a vacuum desiccator containing anhydrous CaCl2. Yield: 87.9 mg (81%). Anal. Calcd for C24H19BrCuN2O4 (542.86): C,53.10; H, 3.52 and N, 5.16. Found: C, 53.12; H, 3.53 and N, 5.17. IR(KBr, cm-1): 3500, 3041, 1986, 1837, 1628, 1590, 1568, 1510, 1418,1344, 1196, 1159, 1106, 993, 855, 773, 720, 672, 631, 551, 548, 528,468, 455, 430.
The synthetic route of 7787-70-4 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Gou, Yi; Zhang, Zhan; Qi, Jinxu; Liang, Shichu; Zhou, Zuping; Yang, Feng; Liang, Hong; Journal of Inorganic Biochemistry; vol. 153; (2015); p. 13 – 22;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”